IFNGR1 and viral infectious disease: As expected, IFNγ treatment had no effect on EBOV GP/rVSV viral titers in IFNγR-/- cells, indicating that the type II IFN receptor is required for IFNγ-mediated inhibition of virus infection (S3C Fig).